You are here

Article info

Article menu
Download PDFPDF
Basic and translational research
Extended report
Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rβ2 inhibition

Authors

  1. Correspondence to Professor Pierre Miossec, Clinical Immunology Unit, Department of Immunology and Rheumatology, Edouard Herriot Hospital, 5 Place d'Arsonval, 69437 Lyon Cedex 03, France; miossec{at}univ-lyon1.fr
View Full Text

Citation

Toh M, Kawashima M, Hot A, et al
Role of IL-17 in the Th1 systemic defects in rheumatoid arthritis through selective IL-12Rβ2 inhibition
Annals of the Rheumatic Diseases 2010;69:1562-1567.

Publication history

  • Accepted January 31, 2010
  • First published June 11, 2010.
Online issue publication 
October 25, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions